Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis.
复制标题
Siglec-1 在外周血单核细胞上的表达增加及其在类风湿性关节炎中单核细胞对自身抗原的反应中的作用。
DOI:
10.1093/rheumatology/ket342
复制
发表时间:
2014-02
期刊:
影响因子:
--
通讯作者:
Wu, Li-Juan
中科院分区:
文献类型:
--
作者:
Li, Chang;Sun, Yi;Zhong, Ren-Qian;Wu, Li-Juan
OBJECTIVES
Elevated expression of Siglec-1 on circulating monocytes has been reported in some inflammatory and autoimmune diseases, but its expression and role in RA has not been elucidated. The aims of this study were to determine the expression of Siglec-1 in peripheral blood and to explore its role in mononuclear cell reactivity to autoantigen in RA.
METHODS
Siglec-1 protein and mRNA levels in 42 RA patients, 39 OA patients, 28 SLE patients and 42 normal controls were determined by flow cytometry and quantitative RT-PCR, respectively. In addition, 10 patients with active RA received DMARDs for 12 weeks and the frequencies of Siglec-1-positive cells and the 28-joint DAS (DAS28) were assessed before and after therapy. Furthermore, TNF-α, IFN-γ and type II collagen were used to up-regulate Siglec-1. Peripheral blood mononuclear cells (PBMCs) from different groups were stimulated with mitogens or antigens and cell proliferation and cytokine production were determined.
RESULTS
The protein and mRNA levels of Siglec-1 on PBMCs and monocytes in RA patients were significantly higher than those in OA patients and healthy controls. Moreover, the expression of Siglec-1 protein on PBMCs was positively correlated with DAS28, ESR, high-sensitivity CRP and IgM-RF, but not with anti-CCP antibody. Interestingly, Siglec-1 expression was decreased in parallel with the decrease in the DAS28 after 12 weeks of anti-rheumatic treatment. Furthermore, TNF-α, IFN-γ and type II collagen can up-regulate Siglec-1 in PBMCs. Elevated PBMC proliferation and proinflammatory cytokine production to collagen stimulation in RA patients decreased when Siglec-1 was inhibited by anti-Siglec-1 antibodies.
CONCLUSION
Elevated Siglec-1 expression in PBMCs and monocytes can potentially serve as a biomarker for monitoring disease activity in RA. Siglec-1 may also play a proinflammatory role in stimulating lymphocyte proliferation and activation in RA.
登录
查看更多内容
影响因子:
3.7
作者:
Rempel H;Calosing C;Sun B;Pulliam L
通讯作者:
Pulliam L
DOI:
10.3899/jrheum.110168
发表时间:
2011-11
期刊:
The Journal of rheumatology
影响因子:
--
作者:
Lertnawapan R;Bian A;Rho YH;Kawai VK;Raggi P;Oeser A;Solus JF;Gebretsadik T;Shintani A;Stein CM
通讯作者:
Stein CM
影响因子:
4.9
作者:
Vander Cruyssen B;Van Looy S;Wyns B;Westhovens R;Durez P;Van den Bosch F;Veys EM;Mielants H;De Clerck L;Peretz A;Malaise M;Verbruggen L;Vastesaeger N;Geldhof A;Boullart L;De Keyser F
通讯作者:
De Keyser F
DOI:
10.3899/jrheum.091364
发表时间:
2010-03
期刊:
The Journal of Rheumatology
影响因子:
--
作者:
B. Nakken;P. Szodoray
通讯作者:
B. Nakken;P. Szodoray
影响因子:
2.7
作者:
Cylwik, B.;Chrostek, L.;Szmitkowski, M.
通讯作者:
Szmitkowski, M.